The new generation troponin I assay unveiled by Beckman Coulter is helping improve heart attack diagnosis. Delivering high sensitivity, and rapid result turnaround times, every element of the Access hsTnI assay has been redeveloped and updated, including the antibodies and the paramagnetic particles used. As specialists in developing and manufacturing products that simplify and automate complex…
Contec Medical Systems (Qinhuangdao) Co., Ltd., Stock Code: 300869 was officially listed on August 24, 2020. The company currently has a market capitalisation of more than 50 billion yuan.
Large proportions of patients can be safely triaged either to rule out discharge or rule in lifesaving management – if following the European Society of Cardiology (ESC) Guidelines Class I recommendation of two serial measurements of hs-cTnI on admission and after one hour, if there are assay specific cut off values for the 0/1 algorithms. The Pathfast hs-cTNI assay is an approved system to…
Cardiology tends to be surrounded by a maze of regulations, responsibilities and red tape. Leave it to the traditionally mercantile Dutch to streamline things. Case in point: HartKliniek, a chain of medical specialist diagnosis and treatment centres in the Netherlands which aim to transform cardiology to a more effective model – less personnel, more time for patients. We spoke with Menno and…
A study conducted by Richard Vander Heide, MD, PhD, Professor and Director of Pathology Research at LSU Health New Orleans School of Medicine, and Marc Halushka, MD, PhD, Professor of Pathology at Johns Hopkins University School of Medicine, suggests myocarditis caused by COVID-19 may be a relatively rare occurrence.
Over-activity in a single brain region called the subgenual anterior cingulate cortex (sgACC) underlies several key symptoms of mood and anxiety disorders, but an antidepressant only successfully treats some of the symptoms. A new study suggests that sgACC is a crucial region in depression and anxiety, and targeted treatment based on a patient's symptoms could lead to better outcomes.
An up-and-coming gene therapy for blood disorders. A new class of medications for cystic fibrosis. Increased access to telemedicine. These are some of the innovations that will enhance healing and change healthcare in the coming year, according to a distinguished panel of clinicians and researchers from Cleveland Clinic. In conjunction with the 2020 Medical Innovation Summit, Cleveland Clinic…
The Society for Cardiovascular Magnetic Resonance (SCMR), a Society dedicated to improving cardiovascular health by advancing the field of cardiovascular magnetic resonance (CMR), has released a formal statement supporting and explaining their position on the use of CMR in COVID-19 patients. The topic has led to debate among medical professionals, especially those in the cardiology specialty.
COVID-19 patients can suffer long-term lung and heart damage but, for many, this tends to improve over time, according to the first, prospective follow-up of patients infected with the coronavirus, presented at the European Respiratory Society International Congress. [1]
Heart patients hospitalised with COVID-19 can safely continue taking angiotensin-converting enzyme (ACE) inhibitors and angiotensin receptor blockers (ARBs), according to the BRACE CORONA trial presented in a Hot Line session today at ESC Congress 2020.(1)
Researchers hope combining a dual-chamber pacemaker with a Closed Loop Stimulation algorithm could lead to a change of emphasis in clinical practice and help reduce unexplained fainting in more patients with recurrent episodes due to skipped heartbeats.
A survey of nurses caring for children with heart problems has revealed that more than half are emotionally exhausted. The analysis, presented at ESC Congress 2020, also found that good working environments were linked with less burnout.
Bacteria and other microorganisms in the digestive tract are linked with dozens of health conditions including high blood pressure, high blood lipids, and body mass index (BMI) according to research presented at ESC Congress 2020. “Our study indicates that microbiota might have an important role in maintaining health and could help us develop novel treatments,” said study author Dr. Hilde…
For cardiology patients fitted with an implantable cardiac monitor, cardioverter defibrillator (ICD) or pacemaker, home monitoring is a blessing. The system also has many advantages for medical staff, as Kristina Rauholt reports. The nurse and Certified Cardiac Device Specialist for Allied Professionals (CCDS) at the Sahlgrenska University Hospital, in Sweden, has worked with home monitoring…
Michigan State University researchers have created for the first time a miniature human heart model in the laboratory, complete with all primary heart cell types and a functioning structure of chambers and vascular tissue.
While about a quarter of physicians and researchers working in advanced heart failure (HF) and transplant cardiology are women, representation of women leading HF research remains limited, according to new research led by Penn Medicine. The authors say the findings point to a need to support great gender diversity among researchers to drive diversity among clinical trial participants and even…
Pupil size predicts death and hospital readmission in patients with heart failure, according to new research. “Our results suggest that pupil area is a novel way to identify heart patients at elevated risk of death or hospital readmission,” said study author Dr. Kohei Nozaki of Kitasato University Hospital, Kanagawa, Japan. “This provides an opportunity to intervene and improve outlook.”
Patient data are a treasure trove for AI researchers. There’s a problem though: many algorithms used to mine patient data act as black boxes, which makes their predictions often hard to interpret for doctors. Researchers from Eindhoven University of Technology (TU/e) and the Zhejiang University in China have now developed an algorithm that not only predicts hospital readmissions of heart…
Is my heart beating slightly fast? Is a heart attack coming? I didn’t sleep as much as I thought I had last night – is that bad for my heart? Health apps and fitness watches can shed considerable light on how our bodies work and make recommendations for a healthy lifestyle. However, self-measuring can have a downside too, according to a new study that examined the experiences of 27 heart…
Bringing a little bit of science fiction into an operating room, a team of engineers and physicians at Washington University in St. Louis has shown for the first time that using a holographic display improves physician accuracy when performing a procedure to treat irregular heartbeat. Jennifer N. Avari Silva, MD, associate professor of pediatrics at the School of Medicine, and Jonathan Silva,…
A team of researchers led by the University of Adelaide and University of Stuttgart has used 3D micro-printing to develop the world’s smallest, flexible scope for looking inside blood vessels. The camera-like imaging device can be inserted into blood vessels to provide high quality 3D images to help scientists better understand the causes of heart attack and heart disease progression, and could…
Half of COVID-19 patients who received a heart scan in hospital showed abnormalities in heart function, according to new research funded by the British Heart Foundation (BHF). The study, published in the European Heart Journal - Cardiovascular Imaging, found that around one in seven showed severe abnormalities likely to have a major effect on their survival and recovery. It also showed that one…
East Germany has many more hospitalisations for heart failure compared to West Germany despite a nationwide healthcare system, according to research presented today on HFA Discoveries, a scientific platform of the European Society of Cardiology (ESC). Heart failure is the most common reason for hospital admissions and is responsible for a large part of the total health expenditure on…
A new polymeric heart valve with a life span potentially longer than current artificial valves that would also prevent the need for the millions of patients with diseased heart valves to require life-long blood thinning tablets has been developed by scientists at the universities of Bristol and Cambridge. The team's latest in-vitro results, published in Biomaterials Science, suggest that the…
Royal Philips and Leeds Teaching Hospitals NHS Trust announced a seven-year managed service agreement to deliver on the Trusts’ vision to set new standards of excellence for cardiac care in the UK and globally. The partnership will combine the latest innovations in technology for integrated cardiovascular solutions to deliver on the quadruple aim: better health outcomes, lower cost of care, and…